Investor Presentation
Texas
Summary
We are one of only three vertical license holders in the second most populous state in the country.
significant potential for 1st mover advantage
Market dynamics are similar to Florida in 2016
-
Medicinal uses for cannabis include epilepsy, terminal cancer, autism seizures and multiple sclerosis.
Recent Texas legislation adds PTSD to the list of qualifying conditions, enables DPS to expand the
medical cannabis program, and raises THC levels to 1%
Existing cultivation facility in Schulenburg, TX with the right to expand up to 400,000 sq. ft.
•
1,300 sq. ft. of cultivation space in climate and humidity-controlled C-containers
Includes 1,920 sq. ft. of flowering canopy over 2 levels
Recent Highlights:
Recorded first B2B sale in TX in Q2 2023
Hired a President and dedicated team to run state operations
Completed first sale of THC in April 2023
Implemented an advertising campaign to build awareness for new patients
On track to open the Company's first delivery center in Houston, TX
FLUENT
Investor Presentation 12View entire presentation